6sense is on a mission to revolutionize the way B2B organizations create revenue by predicting customers most likely to buy and recommending the best course of action to engage anonymous buying teams. 6sense Revenue AI is the only sales and marketing platform to unlock the ability to create, manage and convert high-quality pipeline to revenue. Customers report 2X increases in average contract value, 4X increases in win rate and 20-40% reduction in time to close deals. Know everything, do anything, with 6sense.
Accacia is an AI-enabled platform to help real estate and infrastructure companies (developers, asset managers, financial institutions, operators, and governments) meet their net-zero goals. Real estate and infrastructure contribute to ~44% of global CO2 emissions and at the given speed, it’s expected to cost the world's financial sector $24.2tn, making it one of the most critical sectors to tackle the #climatechange problem. Our platform automates the measurement of scope 1, 2, and 3 carbon emissions for operating assets, and embodied carbon for under-construction assets.
Aetion delivers real-world evidence (RWE) and outcomes-based analytics solutions to life sciences companies, payers, and at-risk providers. With its patented rapid-cycle analytics technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in inpatient care. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Greenspring Associates, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Amgen Ventures, Johnson & Johnson Innovation — JJDC, Inc., UCB, and Horizon Health Services, Inc.
We are one of the largest independent automated driving technology providers in the world. Our holistic approach to driving automation tackles three main industry challenges: software, development and validation tools, and processing hardware. Our team of over 230 works in offices in the USA, Japan, and Hungary to ensure our products are solving the real-world challenges of driving automation. We rely on our team’s expertise in artificial intelligence, sensor fusion, 3D graphics and real-world automated driving workloads, developed utilizing our global test fleet to provide robust solutions. As a result, our market-ready products can accelerate the safe and affordable deployment of ADAS and automated driving bringing these life-saving technologies to the public sooner.
Robots have the potential to reshape our existence. Our mission is to leverage robotics to improve universal quality of life. Robots will become one of the most impactful and effective tools humanity has ever created. We believe robots should do the work humans don’t want to do. We pursue ambitious goals to make this a reality. We’re not satisfied making incremental improvements to the status quo but are driven to change the paradigm altogether. Our robots are versatile, capable of solving numerous tasks with a single embodiment.
Arta Finance is the digital family office for the world. It empowers more people to gain the financial superpowers that, until now, were only accessible by ultra-high-net-worth individuals. Traditional family offices typically hire teams of professionals to access sophisticated financial strategies, exclusive investment opportunities, or connections to finance and lifestyle professionals. Through technology, Arta aims to bring these advantages to millions more people globally.
